| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2011 | US20110166212 Gene expression and pain |
| 07/07/2011 | US20110166211 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 07/07/2011 | US20110166210 Improved expression of il-12 family heterodimers |
| 07/07/2011 | US20110166209 Compositions and methods for ameliorating myosin viia defects |
| 07/07/2011 | US20110166207 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit |
| 07/07/2011 | US20110166206 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells |
| 07/07/2011 | US20110166205 Substituted alpha-l-bicyclic nucleosides |
| 07/07/2011 | US20110166204 Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use |
| 07/07/2011 | US20110166203 Anti-hepatitis c virus composition |
| 07/07/2011 | US20110166202 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/07/2011 | US20110166201 Mirnas as therapeutic targets in cancer |
| 07/07/2011 | US20110166200 Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer |
| 07/07/2011 | US20110166199 RNAi COMPOUND TARGETED TO THROMBOSPONDIN-1 AND APPLICATIONS THEREOF |
| 07/07/2011 | US20110166198 Rna compositions for modulating immune response |
| 07/07/2011 | US20110166197 Antisense Modulation Of Amyloid Beta Protein Expression |
| 07/07/2011 | US20110166196 Treatment and prophylaxis of epilepsy and febrile seizures |
| 07/07/2011 | US20110166195 Method for the formation of megamitochondria |
| 07/07/2011 | US20110166194 Asenapine Prodrugs |
| 07/07/2011 | US20110166191 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer |
| 07/07/2011 | US20110166190 Methods of treating mammals with eustachian tube dysfunctions |
| 07/07/2011 | US20110166189 Methods of using sustained release aminopyridine compositions |
| 07/07/2011 | US20110166188 Methods of using sustained release aminopyridine compositions |
| 07/07/2011 | US20110166187 Methods of using sustained release aminopyridine compositions |
| 07/07/2011 | US20110166186 Methods of administering pirfenidone therapy |
| 07/07/2011 | US20110166185 Disease risk factors and methods of use |
| 07/07/2011 | US20110166183 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 07/07/2011 | US20110166182 Selective Estrogen Receptor Modulator for the Treatment of Osteoarthritis |
| 07/07/2011 | US20110166181 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/07/2011 | US20110166180 Method for treatment of bone diseases and fractures |
| 07/07/2011 | US20110166179 Antibacterial quinoline derivatives |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166177 Bis-quaternary ammonium salts as pain modulating agents |
| 07/07/2011 | US20110166176 Compounds and compositions as modulators of gpr119 activity |
| 07/07/2011 | US20110166175 7-azaindole derivatives |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 07/07/2011 | US20110166172 Rapamycin Carbonic Ester Analogues, Pharmaceutical Compositions, Preparations and Uses Thereof |
| 07/07/2011 | US20110166171 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 07/07/2011 | US20110166170 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 07/07/2011 | US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof |
| 07/07/2011 | US20110166168 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
| 07/07/2011 | US20110166167 Bicyclic heterocycle derivatives and methods of use thereof |
| 07/07/2011 | US20110166166 Methods for detection of biological substances |
| 07/07/2011 | US20110166165 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 07/07/2011 | US20110166164 THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS |
| 07/07/2011 | US20110166163 Substituted furopyrimidines and use thereof |
| 07/07/2011 | US20110166161 Heterocyclic carboxamide compounds |
| 07/07/2011 | US20110166160 Pyrazinone Modulator of Corticotropin-Releasing Factor Receptor Activity |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |
| 07/07/2011 | US20110166158 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/07/2011 | US20110166157 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease |
| 07/07/2011 | US20110166156 Prodrugs for the Treatment of Schizophrenia and Bipolar Disease |
| 07/07/2011 | US20110166155 Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators |
| 07/07/2011 | US20110166154 Identification of predictive markers of response to dasatinib in human colon cancer |
| 07/07/2011 | US20110166153 Protein Kinase Targeted Therapeutics |
| 07/07/2011 | US20110166152 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/07/2011 | US20110166151 Glucocorticoid receptor agonist comprising 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 07/07/2011 | US20110166150 Anhydrous Crystal Form Of Ovrepitant Maleate |
| 07/07/2011 | US20110166149 Pteridine derivatives for treating respiratory disease |
| 07/07/2011 | US20110166148 Treatment of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/07/2011 | US20110166147 Imidazopyrazine compounds |
| 07/07/2011 | US20110166146 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166144 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same |
| 07/07/2011 | US20110166142 2-substituted isoflavonoid compounds, medicaments and uses |
| 07/07/2011 | US20110166141 Cathepsin s inhibitors |
| 07/07/2011 | US20110166140 Novel sulphonylpyrroles |
| 07/07/2011 | US20110166139 Pyridine compounds |
| 07/07/2011 | US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors |
| 07/07/2011 | US20110166137 Substituted Naphthalenyl-Pyrimidine Compounds |
| 07/07/2011 | US20110166136 Calcium Ion Channel Modulators & Uses Thereof |
| 07/07/2011 | US20110166135 Aromatic nitrogen-containing 6-membered ring compounds and their use |
| 07/07/2011 | US20110166134 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease |
| 07/07/2011 | US20110166133 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 07/07/2011 | US20110166132 Gamma Secretase Modulators |
| 07/07/2011 | US20110166131 Substituted pyrrolidine derivative |
| 07/07/2011 | US20110166130 Novel potassium channel blockers and uses thereof |
| 07/07/2011 | US20110166129 Inhibitors of janus kinases |
| 07/07/2011 | US20110166128 Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders |
| 07/07/2011 | US20110166127 Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds |
| 07/07/2011 | US20110166126 Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones |
| 07/07/2011 | US20110166125 Substituted amides, manufacturing and use thereof as medicaments |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |
| 07/07/2011 | US20110166123 Novel compositions and methods of use |
| 07/07/2011 | US20110166122 SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 07/07/2011 | US20110166121 Fused heterocyclic compound |
| 07/07/2011 | US20110166120 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 07/07/2011 | US20110166119 Synergistic Combinations of Aztreonam with the Carbapenems Meropenem and Ertapenem |
| 07/07/2011 | US20110166118 New trinem antibiotics and inhibitors of beta-lactamases |
| 07/07/2011 | US20110166117 Novel Compounds |
| 07/07/2011 | US20110166116 New compounds, pharmaceutical composition and methods relating thereto |
| 07/07/2011 | US20110166115 Use of mifepristone for the treatment of amyotrophic lateral sclerosis |
| 07/07/2011 | US20110166114 Method for treating snoring and sleep apnea with leukotriene antagonists |
| 07/07/2011 | US20110166113 Method for treating the hyperpigmentation of pathological scars |
| 07/07/2011 | US20110166112 Method for stimulating platelet production |
| 07/07/2011 | US20110166111 Composition for the reduction of drip losses in pork |
| 07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 07/07/2011 | US20110166108 Methods of use related to xerostomia |
| 07/07/2011 | US20110166107 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| 07/07/2011 | US20110166106 Artemisinin and derivatives thereof as antivirals |